Vance Vanier

Vance Vanier is a healthcare executive and venture capitalist. Vance is currently a board member at Tredence, and was previously the CEO of Navigenics, a preventative genomics company that was acquired by Life Technologies. Dr. Vanier also served as Chief Medical Officer at Navigenics from 2008 to 2009, and was a venture capitalist at Mohr Davidow Ventures from 2006 to 2008.

Vance Vanier has an MBA from Stanford University Graduate School of Business and an M.D. from The Johns Hopkins University School of Medicine.